Trials
Search / Trial NCT05659121

Improving Mobility Via Robotic Exoskeletons in Local Rehabilitation Settings in Singapore

Launched by NATIONAL UNIVERSITY HOSPITAL, SINGAPORE · Dec 19, 2022

Trial Information

Current as of January 21, 2025

Completed

Keywords

ClinConnect Summary

In recent years, robot-assisted gait training has been increasingly applied in various rehabilitation facilities across Singapore. Thus far, all systems in Singapore are tethered to treadmills or other platforms. These are bulky, expensive, and the 'gait' trained differs from normal gait to varying degrees. Such systems are found only in hospitals and major centres with significant space and financial resources. No evaluation of cost-effectiveness has been performed thus far. With appropriate and efficient clinical protocols adapted and optimised for the Singapore context, study team plans ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age between 21 to 90 years old;
  • 2. Functional Ambulatory Category (FAC) 0-3;
  • 3. Able to follow instructions adequately to ensure safe use of the exoskeleton.
  • Exclusion Criteria
  • 1. Severe osteoporosis;
  • 2. Uncontrolled medical conditions (eg. Unstable angina, untreated hypertension);
  • 3. Terminal disease with expected survival \<1 year;
  • 4. Pressure sores or wounds at point of contact with exoskeleton;
  • 5. Severe limitations of range of movement in the lower limb (eg. from contractures or spasticity);
  • 6. Lower limb fractures that have not been fixed or are deemed not stable enough for training with exoskeleton;
  • 7. Cognitive impairment so as to be unable to follow instructions;
  • 8. Significant pain in the lower limbs.
  • 9. Pregnancy

Trial Officials

Effie Chew, MBBS

Principal Investigator

Senior Consultant

About National University Hospital, Singapore

National University Hospital (NUH) in Singapore is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, NUH emphasizes a multidisciplinary approach, integrating cutting-edge medical research with high-quality patient care. The hospital collaborates with various stakeholders, including academic institutions and industry partners, to explore new therapies and improve treatment outcomes across a wide range of medical disciplines. Committed to ethical standards and patient safety, NUH plays a pivotal role in shaping the future of medicine in Singapore and beyond.

Locations

Singapore, , Singapore

Singapore, , Singapore

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials